Mitsubishi Ufj Trust & Banking Corp Vertex Pharmaceuticals Inc Transaction History

Mitsubishi Ufj Trust & Banking Corp

$41.5 Billion
Q2 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 190,128 shares of VRTX stock, worth $98.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

190,128

Previous 213,590 10.98%

Holding current value

$98.2 Million

Previous $89.3 Million 0.19%

% of portfolio

0.21%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $9.22 Million - $11.4 Million	-23,462 Reduced 10.98%	190,128 $89.1 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $6.53 Million - $7.15 Million	-16,028 Reduced 6.98%	213,590 $89.3 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $6.89 Million - $8.25 Million	20,090 Added 9.59%	229,618 $93.4 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $2.39 Million - $2.57 Million	-7,080 Reduced 3.27%	209,528 $72.9 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $2.1 Million - $2.35 Million	-6,671 Reduced 2.99%	216,608 $76.2 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $3.31 Million - $3.78 Million	-11,693 Reduced 4.98%	223,279 $70.3 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $2.52 Million - $2.83 Million	-8,809 Reduced 3.61%	234,972 $67.9 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $9.42 Million - $10.5 Million	-34,409 Reduced 12.37%	243,781 $70.6 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $7.62 Million - $9.49 Million	32,446 Added 13.2%	278,190 $78.4 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $2 Million - $2.36 Million	-9,025 Reduced 3.54%	245,744 $64.1 Million
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $3.18 Million - $4.02 Million	-17,977 Reduced 6.59%	254,769 $55.9 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $298,023 - $333,512	1,643 Added 0.61%	272,746 $49.5 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $1.34 Million - $1.58 Million	7,140 Added 2.7%	271,103 $54.6 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $13.1 Million - $15.3 Million	-63,204 Reduced 19.32%	263,963 $56.9 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $16.3 Million - $21.7 Million	78,637 Added 31.64%	327,167 $77.3 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $993,967 - $1.18 Million	3,888 Added 1.59%	248,530 $67.6 Million
Q2 2020 Sep 11, 2020	SELL	$225.48 - $295.8 $5.49 Million - $7.2 Million	-24,353 Reduced 9.05%	244,642 $71 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $13.3 Million - $17.4 Million	58,900 Added 28.03%	268,995 $71 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $2.8 Million - $3.48 Million	14,035 Added 7.16%	210,095 $50 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $51,846 - $69,636	-311 Reduced 0.16%	196,060 $42.9 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $497,858 - $560,334	-2,995 Reduced 1.5%	196,371 $32.8 Million
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $7.04 Million - $8.14 Million	-42,783 Reduced 17.67%	199,366 $35.6 Million
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $15.2 Million - $18.1 Million	-93,050 Reduced 27.76%	242,149 $44.2 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $854,341 - $1.08 Million	-5,624 Reduced 1.65%	335,199 $55.5 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $55 Million - $63.2 Million	-327,920 Reduced 49.04%	340,823 $65.7 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $812,680 - $947,866	5,577 Added 0.84%	668,743 $114 Million
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $356,411 - $416,432	2,351 Added 0.36%	663,166 $108 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $58,344 - $66,108	425 Added 0.06%	660,815 $99 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $97.8 Million - $107 Million	660,390	660,390 $100 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account

Mitsubishi Ufj Trust & Banking Corp Vertex Pharmaceuticals Inc Transaction History